Schneiderman Prelims Vol-I. qxd

DEGENERATIVE
Age-related fine wrinkling (crinkling) and laxity 
Rook
p.2004,2019, 1998, Sixth Edition
DRUG-INDUCED
Atrophic scars secondary to drug eruption
Bleomycin – scaly linear erythema of dorsa of hands
with atrophy and telangiectasia (dermatomyositis-like)
JAAD 48:439–441, 2003
Corticosteroid atrophy – systemic, intralesional, topical
corticosteroids 
Rook p.2006–2007,3550, 1998, Sixth Edition;
AD 126:1013–1014, 1990; perilesional linear atrophic streaks
Ped Derm 4:259–260, 1987; linear atrophy due to intralesional
corticosteroid injections of de Quervain tendonitis 
Cutis
73:197–198, 2004; oral, inhaled, topical-induced acne rosacea –
papules, pustules, atrophy, telangiectasia 
Clin Exp Dermatol
18:148–150, 1993; AD Forsch 247:29–52, 1973; multifocal
lipoatrophy due to intravenous cortisol 
JAAD 46:S130–132,
2002; striae; intra-articular corticosteroid injection
Hydroxyurea – atrophic, scaling, poikilodermatous patches
with erosions on the backs of the hands, sides of the feet 
JAAD
45:321–322, 2001; atrophy of skin and subcutaneous tissue
JAAD 36:178–182, 1997
Indinivir (protease inhibitor) – striae 
JAAD 41:467–469, 1999;
lipodystrophy and abnormal fat distribution (crix belly – central
adiposity) 
JAAD 46:284–293, 2002
Insulin injection lipoatrophy – dimple or more extensive area of
atrophy 
Ped Derm 11:310–314, 1994
Methimazole and carbimazole – aplasia cutis congenita 
Ped
Derm 3:327–330, 1986
Methotrexate – semicircular lipoatrophy 
Ped Derm 19:432–435,
2002
Misoprostol – extensive frontotemporal defects of scalp and
temporal bones 
Clin Dysmorphol 2:76–80, 1993
Nelfinavir (protease inhibitor) – lipodystrophy and abnormal fat
distribution (crix belly – central adiposity); striae 
JAAD
46:284–293, 2002
Penicillamine dermatopathy 
AD 125:92–97, 1989
Phytonadione (fat soluble vitamin K) injection – sclerodermiform
atrophic plaques
AD 137:957–962, 2001; AD 121:1421–1423,
1985; Cutis 43:364–368, 1989; JAAD 38:322–324, 1998; Cutis
61:81–83, 1998
Protease inhibitors – facial lipoatrophy 
BJD 142:496–500, 2000;
lipodystrophy of face, arms, legs, and buttocks with central fat
accumulation of abdomen, breasts, and dorsocervical fat pad
JAAD 50:809–810, 2004
Saltpeter-induced PXE like changes
Saquinavir (protease inhibitor) – lipodystrophy and abnormal fat
distribution (crix belly – central adiposity); striae 
JAAD
46:284–293, 2002